288 related articles for article (PubMed ID: 25354177)
21. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
22. Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.
Krogstad EA; Ramanathan R; Nhan C; Kraft JC; Blakney AK; Cao S; Ho RJY; Woodrow KA
Biomaterials; 2017 Nov; 144():1-16. PubMed ID: 28802690
[TBL] [Abstract][Full Text] [Related]
23. Vaginal mucoadhesive drug delivery systems.
de Araújo Pereira RR; Bruschi ML
Drug Dev Ind Pharm; 2012 Jun; 38(6):643-52. PubMed ID: 21999572
[TBL] [Abstract][Full Text] [Related]
24. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
das Neves J; Amiji M; Sarmento B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
[TBL] [Abstract][Full Text] [Related]
25. Gels as vaginal drug delivery systems.
das Neves J; Bahia MF
Int J Pharm; 2006 Aug; 318(1-2):1-14. PubMed ID: 16621366
[TBL] [Abstract][Full Text] [Related]
26. Nanotechnology platforms; an innovative approach to brain tumor therapy.
Nair BG; Varghese SH; Nair R; Yoshida Y; Maekawa T; Kumar DS
Med Chem; 2011 Sep; 7(5):488-503. PubMed ID: 21801148
[TBL] [Abstract][Full Text] [Related]
27. Progresses in Nano-Enabled Platforms for the Treatment of Vaginal Disorders.
Patel R; Yadav BK; Patel G
Recent Pat Nanotechnol; 2023; 17(3):208-227. PubMed ID: 35762539
[TBL] [Abstract][Full Text] [Related]
28. The Know-how of Polymeric Nanocarrier Based Vaginal Drug Delivery System: Pitfalls, Challenges and Trends.
Kanojiya P; Wadetwar R; Karemore M; Prasad S
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38279713
[TBL] [Abstract][Full Text] [Related]
29. Emerging Use of Nanotechnology in the Treatment of Neurological Disorders.
Chhabra R; Tosi G; Grabrucker AM
Curr Pharm Des; 2015; 21(22):3111-30. PubMed ID: 26027574
[TBL] [Abstract][Full Text] [Related]
30. Miniaturized Polymeric Systems for the Intravaginal Gene Therapies: Recent Update on Unconventional Delivery.
Pandey M; Ting JSS; Gorain B; Jain N; Mayuren J
Curr Pharm Des; 2023; 29(40):3254-3262. PubMed ID: 37438899
[TBL] [Abstract][Full Text] [Related]
31. In vitro and ex vivo models for evaluating vaginal drug delivery systems.
Shapiro RL; DeLong K; Zulfiqar F; Carter D; Better M; Ensign LM
Adv Drug Deliv Rev; 2022 Dec; 191():114543. PubMed ID: 36208729
[TBL] [Abstract][Full Text] [Related]
32. Vaginal drug delivery system: A promising route of drug administration for local and systemic diseases.
Subi MTM; Selvasudha N; Vasanthi HR
Drug Discov Today; 2024 Jun; 29(6):104012. PubMed ID: 38705512
[TBL] [Abstract][Full Text] [Related]
33. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery.
Roger E; Lagarce F; Garcion E; Benoit JP
Nanomedicine (Lond); 2010 Feb; 5(2):287-306. PubMed ID: 20148639
[TBL] [Abstract][Full Text] [Related]
34. Mucoadhesive and thermogelling systems for vaginal drug delivery.
Caramella CM; Rossi S; Ferrari F; Bonferoni MC; Sandri G
Adv Drug Deliv Rev; 2015 Sep; 92():39-52. PubMed ID: 25683694
[TBL] [Abstract][Full Text] [Related]
35. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems.
Pereira MN; Reis TA; Matos BN; Cunha-Filho M; Gratieri T; Gelfuso GM
Colloids Surf B Biointerfaces; 2017 Oct; 158():222-228. PubMed ID: 28697437
[TBL] [Abstract][Full Text] [Related]
36. Stimuli-responsive nanoplatforms for antibacterial applications.
Huang Y; Zou L; Wang J; Jin Q; Ji J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
[TBL] [Abstract][Full Text] [Related]
37. Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.
Zierden HC; Josyula A; Shapiro RL; Hsueh HT; Hanes J; Ensign LM
Trends Mol Med; 2021 May; 27(5):436-450. PubMed ID: 33414070
[TBL] [Abstract][Full Text] [Related]
38. Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.
Wu N; Zhang X; Li F; Zhang T; Gan Y; Li J
Int J Nanomedicine; 2015; 10():5383-96. PubMed ID: 26347257
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
[TBL] [Abstract][Full Text] [Related]
40. Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.
Ensign LM; Hoen TE; Maisel K; Cone RA; Hanes JS
Biomaterials; 2013 Sep; 34(28):6922-9. PubMed ID: 23769419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
